Abstract:Multiple myeloma (MM) is an indolent B-cell disease characterized by clonal proliferation of malignant plasma cells. Multiple myeloma remains incurable despite new targeted drugs and development of drug resistance or intolerable toxicity emerges as a major problem. Therefore, design, identification, and validation of novel chemicals with therapeutic potential are clearly needed for MM treatment. Here, we explore polyphyllin I (PPI), a major active constituent extracted from Paris polyphyllin, its inhibitory effects and its mechanisms in MM cells in vitro. We found that PPI inhibited the proliferation of myeloma cells. The combination of PPI with dexamethasone, doxorubicin, arsenic trioxide, or bortezomib enhanced the inhibition of cell growth. As analyzed by flow cytometry, MM cells were arrested at G2/M phase and apoptotic cells increased in a time-dependent manner. Morphological changes of cells undergoing apoptosis were observed under light microscope. To explore the mechanism of apoptosis induced by PPI, we next examined whether the Wingless-Int (Wnt)/-catenin signaling pathway played a role in the PPI-induced growth inhibition in MM cells. The canonical Wnt signaling pathway is activated in MM cells through constitutively active -catenin, a messenger molecule relevant to growth, survival, and migration of MM cells. Western blotting was used to measure the protein levels of -catenin, and PPI treatment led to downregulating the expression of -catenin protein and was followed by inhibition of -catenin nuclear localization. As a result, -catenin downstream targets, such as cyclin D1 and survivin, were downregulated. To the best of our knowledge, this is the first report identifying anti-proliferative potency of PPI against myeloma cells. PPI blocks -catenin nuclear translocation and decreasing expression of the downstream targets of -catenin. Our results suggest that PPI is a novel inhibitor of -catenin activity with potential anti-myeloma efficacy.

Gossypol induces apoptosis of multiple myeloma cells through the JUN-JNK pathway.

Molecular Mechanism of Gossypol-Induced Cell Growth Inhibition and Cell Death of HT-29 Human Colon Carcinoma Cells.

Gossypol induces apoptosis in ovarian cancer cells through oxidative stress.

Gambogenic Acid Exerts Antitumor Activity in Hypoxic Multiple Myeloma Cells by Regulation of Mir-21

Gossypol induces apoptosis of human pancreatic cancer cells via CHOP/endoplasmic reticulum stress signaling pathway

Apoptosis of multiple myeloma cells induced by gossypol acetic acid in vitro and its mechanism]

HMGB1 Knockdown Increases MM Cell Vulnerability by Regulating Autophagy and DNA Damage Repair

Bioinformatics Analysis Of The Signaling Pathways And Genes Of Gossypol Induce Death Of Nasopharyngeal Carcinoma Cells

Gossypol induces apoptosis in human PC-3 prostate cancer cells by modulating caspase-dependent and caspase-independent cell death pathways.

Gossypol Induces Bax/Bak-Independent Activation of Apoptosis and Cytochrome C Release Via A Conformational Change in Bcl-2

Involvement of Bcl-2, Src, and ERα in Gossypol-Mediated Growth Inhibition and Apoptosis in Human Uterine Leiomyoma and Myometrial Cells

[Berbamine induces apoptosis of multiple myeloma RPMI 8226 cells by activating GADD45/JNK pathway].

Polyphyllin I Induces Cell Cycle Arrest and Apoptosis in Human Myeloma Cells Via Modulating Β‐catenin Signaling Pathway

Effects of Gossypol on the Proliferation and Apoptosis of Jurkat T Cells

Differential Growth Inhibition and Induction of Apoptosis by Gossypol Between Hct116 and Hct116/Bax(-/-) Colorectal Cancer Cells

A Gli inhibitor GANT61 suppresses cell proliferation, promotes cell apoptosis and induces G1/G0 cycle retardation with a dose- and time-dependent manner through inhibiting Notch pathway in multiple myeloma

Gossypol Acetate Induces Apoptosis in RM-1 Prostate Cancer Cells

Synergistic cytotoxicity of Bcl-xL inhibitor, gossypol and chemotherapeutic agents in non-Hodgkin’s lymphoma cells

Natural BH3 Mimetic (-)-gossypol Chemosensitizes Human Prostate Cancer Via Bcl-xL Inhibition Accompanied by Increase of Puma and Noxa

Taurine attenuates gossypol-induced apoptosis of C2C12 mouse myoblasts via the GPR87-AMPK/AKT signaling

The tubulin polymerization inhibitor gambogenic acid induces myelodysplastic syndrome cell apoptosis through upregulation of Fas expression mediated by the NF-κB signaling pathway